GNPX
Genprex, Inc.Congress Trades
| Name | Value | Action | Amount Range | Price | Last Price |
|---|---|---|---|---|---|
Tim MooreRepublican $8k BuyFeb 5, 2026 $1k-$15k -- $7.67 | |||||
Tim MooreRepublican $8k BuyDec 18, 2025 $1k-$15k -- $7.67 | |||||
Tim MooreRepublican $8k BuyNov 7, 2025 $1k-$15k -- $7.67 | |||||
Insider Trades
News
prnewswire.comPositive Clinical Data on Biomarkers in Patients Receiving Reqorsa® Gene Therapy Published at the 2026 ASCO Annual Meetingprnewswire.comMay 26
prnewswire.comGenprex Collaborators Present Positive Preclinical Data on Diabetes Gene Therapy for Type 2 Diabetes at the 2026 American Society of Gene and Cell Therapy Annual Meetingprnewswire.comMay 14
prnewswire.comGenprex Receives Patent Grant from The Israel Patent Office for the Combination of Reqorsa® Gene Therapy and PD-1 Antibodies to Treat Cancerprnewswire.comApr 30
prnewswire.comGenprex Collaborators to Present Positive Preclinical Data on Diabetes Gene Therapy for Type 2 Diabetes at the 2026 American Society of Gene and Cell Therapy Annual Meetingprnewswire.comApr 28
prnewswire.comPositive Clinical Data on Biomarkers in Patients Receiving Reqorsa® Gene Therapy To Be Released at the 2026 ASCO Annual Meetingprnewswire.comApr 22